Does COBIMETINIB Cause Hyperkeratosis? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hyperkeratosis have been filed in association with COBIMETINIB (Cotellic). This represents 0.6% of all adverse event reports for COBIMETINIB.
23
Reports of Hyperkeratosis with COBIMETINIB
0.6%
of all COBIMETINIB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Hyperkeratosis From COBIMETINIB?
Of the 23 reports, 2 (8.7%) resulted in death, 10 (43.5%) required hospitalization, and 6 (26.1%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for COBIMETINIB. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does COBIMETINIB Cause?
Diarrhoea (412)
Off label use (411)
Rash (369)
Pyrexia (332)
Death (231)
Nausea (206)
Fatigue (198)
No adverse event (178)
Vomiting (168)
Acute kidney injury (133)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which COBIMETINIB Alternatives Have Lower Hyperkeratosis Risk?
COBIMETINIB vs COCAETHYLENE
COBIMETINIB vs COCAINE
COBIMETINIB vs COCOA BUTTER\PHENYLEPHRINE
COBIMETINIB vs COD LIVER OIL
COBIMETINIB vs CODEINE